self-medication: participants using a specific analgesic (ibuprofen, paracetamol, aspirin) for pain relief self-medication: participants using a specific antihistamine (dimetindene, loratadine, cetirizine) for itch relief
Conditions
Interventions
Group 1: group itch 1 (n=18): participants read the package insert of the antihistamine. There are no clinical interventions.
Group 2: group itch 2 (n=18): participants read an information focussing o
Sponsors
Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Anästhesiologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: self-medication with an antihistamine (dimetindene/cetirizine/loratadine) to reduce itch intensity or selfmedication with an analgesic (ibuprofen/aspirin,paracetamol) to reduce pain
Exclusion criteria
Exclusion criteria: - symptom intensity < 3 on a numeric rating scale (range 0 to 10) - acute and/or chronic psychiatric disorders (ICD-10) according to participant's statement - poor knowledge of the German language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoints are the symptom reduction (numeric rating scale), medication intake and related side-effects collected via an online survey and a possible paper version (including STAI-S (anxiety), SETS (Stanford Expectations of Treatment Scale; measuring patient outcome expectancy in clinical trials ), PHQ-4 (anxiety and depression) at three points of time: baseline, post1 (after intervention) and post2 (couse over seven days). | — |
Countries
Germany
Contacts
Public ContactAriane Sölle
Universität Hamburg, Institut für Psychologie
Outcome results
None listed